tiprankstipranks
InteliCare Holdings Limited (AU:ICR)
ASX:ICR
Australian Market
Want to see AU:ICR full AI Analyst Report?

InteliCare Holdings Limited (ICR) AI Stock Analysis

105 Followers

Top Page

AU:ICR

InteliCare Holdings Limited

(Sydney:ICR)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
AU$0.02
▲(0.00% Upside)
Action:Reiterated
Date:06/18/26
The score is primarily constrained by weak financial performance: negative gross profit, ongoing losses and cash burn, and negative equity that increases funding and balance-sheet risk. Technical signals are also subdued (negative MACD, RSI below 50, and no clear strength versus longer moving averages). Valuation impact is neutral due to missing P/E and dividend yield data.
Positive Factors
Recurring revenue model
A hardware-plus-subscription model creates recurring revenue and customer lifetime value. Subscriptions for monitoring, analytics and alerts give predictable revenue streams as installed bases grow, supporting durable top-line visibility and scaling economics over months.
Negative Factors
Negative gross profit & weak margins
Persistently negative gross profit shows the cost base exceeds current revenue and implies the core unit economics are not yet viable. Without structural margin improvement—through pricing, cost reduction, or much higher volume—scaling revenue alone may not produce sustainable profitability.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring revenue model
A hardware-plus-subscription model creates recurring revenue and customer lifetime value. Subscriptions for monitoring, analytics and alerts give predictable revenue streams as installed bases grow, supporting durable top-line visibility and scaling economics over months.
Read all positive factors

InteliCare Holdings Limited (ICR) vs. iShares MSCI Australia ETF (EWA)

InteliCare Holdings Limited Business Overview & Revenue Model

Company Description
Operating out of Leederville, Australia, Intelicare Holdings Limited was founded in 2016. The company is dedicated to supplying innovative predictive analytics solutions, delivered as a combined hardware and software package, primarily serving Aus...
How the Company Makes Money
InteliCare Holdings Limited generates revenue through the sale of its monitoring systems and subscription-based services. Customers, including individual consumers, aged care providers, and healthcare facilities, purchase the IoT hardware and pay ...

InteliCare Holdings Limited Financial Statement Overview

Summary
Despite strong FY2025 revenue growth (~45% to ~A$0.96m) and reduced losses versus prior years, the core financial profile remains weak: gross profit is still negative, operating losses persist, cash burn remains large (FY2025 operating cash flow ~-A$1.67m), and equity turned negative (~-A$0.83m), raising balance-sheet and funding risk.
Income Statement
18
Very Negative
Balance Sheet
27
Negative
Cash Flow
21
Negative
BreakdownTTMJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Income Statement
Total Revenue945.45K956.74K280.29K404.35K429.85K363.12K
Gross Profit-1.24M-1.09M-1.79M-2.69M-2.75M-1.99M
EBITDA-2.61M-2.16M-3.02M-2.89M-3.78M-4.24M
Net Income-2.84M-2.24M-2.26M-3.00M-3.93M-4.36M
Balance Sheet
Total Assets1.64M1.02M1.52M2.48M2.88M3.43M
Cash, Cash Equivalents and Short-Term Investments1.05M410.53K834.20K1.94M2.27M2.67M
Total Debt1.09M716.62K612.39K726.57K18.25K85.16K
Total Liabilities1.86M1.86M1.69M1.53M1.34M842.64K
Stockholders Equity-222.63K-833.17K-168.32K949.11K1.54M2.59M
Cash Flow
Free Cash Flow-2.56M-1.67M-1.66M-3.11M-3.14M-3.86M
Operating Cash Flow-2.55M-1.67M-1.66M-3.10M-3.10M-3.79M
Investing Cash Flow-6.45K-7.09K0.00-14.35K-32.92K-74.79K
Financing Cash Flow2.35M1.25M555.65K2.78M2.73M2.34M

InteliCare Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
49
Neutral
AU$4.91M-4.91-42.29%-64.67%
43
Neutral
AU$15.74M-578.72%43.55%26.03%
43
Neutral
AU$63.35M-8.12-59.96%
42
Neutral
AU$6.81M-0.75152.58%-57.91%-9.02%
41
Neutral
AU$3.12M60.7415.41%-5.76%8.00%
41
Neutral
AU$30.65M-5.82-52.26%22.81%-110.26%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:ICR
InteliCare Holdings Limited
0.02
<0.01
57.14%
AU:TD1
Tali Digital
0.11
0.03
50.00%
AU:GLH
Global Health Limited
0.05
>-0.01
-10.17%
AU:SHG
Singular Health Group Ltd
0.20
-0.18
-46.67%
AU:EMD
Emyria Ltd
0.04
<0.01
35.71%
AU:HIQ
HitIQ Limited
0.01
>-0.01
-37.50%

InteliCare Holdings Limited Corporate Events

InteliCare Highlights Digital Intelligence Strategy for Aged Care
Jun 16, 2026
InteliCare Holdings Limited has released an investor presentation outlining its role in using digital intelligence to transform aged care delivery. The company positions itself as a technology partner to aged care providers, highlighting its strat...
InteliCare Confirms Compliance as It Issues Shares from Option Exercises
May 22, 2026
InteliCare Holdings Limited has issued fully paid ordinary shares following the exercise of options, and has notified the ASX under section 708A(5) of the Corporations Act. The company states it is up to date with financial reporting and continuou...
InteliCare Applies for Quotation of Additional Ordinary Shares on ASX
May 22, 2026
InteliCare Holdings Limited has lodged an application with the ASX for quotation of 416,667 new fully paid ordinary shares under code ICR, with an issue date of 22 May 2026. The new securities arise from the exercise or conversion of existing opti...
InteliCare Plans Large Share and Option Issue to Boost Capital Base
May 7, 2026
InteliCare Holdings Limited has announced a proposed capital raising through the issue of 93,000,000 new ordinary fully paid shares and 15,000,000 unlisted options. The unlisted options will be exercisable at $0.04 and are set to expire on 19 May ...
InteliCare Raises A$2.05m to Accelerate Aged Care Tech Scale-Up
May 7, 2026
InteliCare Holdings Limited, an Australian technology provider of AI-powered care platforms for aged care and retirement living, has commercialised a predictive analytics hardware and software system built on an IoT sensor network. The company tar...
InteliCare Seeks Trading Halt Ahead of Capital Raising Announcement
May 4, 2026
InteliCare Holdings Limited has requested a trading halt in its securities on the ASX, effective immediately, as it prepares a market announcement regarding a capital raising. The halt will remain in place until either the capital raising announce...
InteliCare lands landmark mecwacare deal and expands into retirement living
Apr 30, 2026
InteliCare has secured a five-year master subscription agreement with Victorian not-for-profit provider mecwacare to deploy its AI-powered care platform across 22 residential aged care facilities, in a deal worth about $8.8 million on full rollout...
InteliCare Posts Modest Quarterly Cash Outflow Amid Government Support
Apr 30, 2026
InteliCare Holdings Limited reported quarterly customer receipts of A$81,000 and continued investment in research and development, staffing, and corporate functions, resulting in a modest operating cash outflow of A$28,000 for the March 2026 quart...
InteliCare wins first retirement village deal with Warrigal Care
Apr 23, 2026
InteliCare has signed a three-year Master Subscription Agreement with not-for-profit provider Warrigal Care to deploy its sensor-based monitoring platform across 65 two-bedroom villas at a new retirement living development in New South Wales or th...
InteliCare Confirms Compliance in Performance Rights Disclosure
Mar 27, 2026
InteliCare Holdings has issued a notice under section 708A(5) of the Corporations Act confirming the recent issue of performance rights by the company. The board states that the company is fully compliant with its financial reporting and continuou...
InteliCare Plans Issue of 16.5 Million Performance Rights on ASX
Mar 27, 2026
InteliCare Holdings Limited has lodged details with the ASX for a proposed issue of up to 16,500,000 performance rights under the security code ICRAP. The issue is structured as a placement or other type of security issue, with the proposed issue ...
InteliCare to Highlight AI Care Platform at NWR Virtual Healthcare Conference
Mar 25, 2026
InteliCare Holdings Ltd, an Australian SaaS technology company specialising in AI-driven predictive analytics and IoT-based hardware and software for aged care, disability and health, delivers both B2B and B2C solutions. Its platform uses smart se...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 18, 2026